Physician

Brion J Lock, M.D.

According to 2025 Medicare claims, Brion Lock, M.D. (NPI: 1295785731) practices pulmonary disease in the Marietta, GA market, with the plurality of this provider's patient population coming from Cobb, GA. This provider's primary affiliated billing organization is PIEDMONT PROVIDERS LLC (NPI: 1548273592; TIN: 582540874) and primary practice location at 30060-8937. Lock is affiliated with the Piedmont Clinic ACO LLC (ACO ID: A3250), participating under the MSSP model.

Lock's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 737 traditional Medicare patients, billed 8,106 HCPCS/CPT codes, and received $512,426 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 5,681 prescription claims across 767 beneficiaries totaling $2,986,128 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,953 claims. Open Payments data shows 114 records totaling $9,307. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $284,240 to $512,426. Similarly, Part D prescription costs have moved sharply higher in recent years, from $498,948 to $2,986,128. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $77,413 to $286,321.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	789	5,316	$284,240
2016	953	6,667	$314,165
2017	1,017	7,810	$344,332
2018	853	8,698	$367,887
2019	907	9,852	$417,368
2020	765	8,273	$350,517
2021	731	8,658	$464,595
2022	773	8,501	$534,548
2023	758	8,801	$560,323
2024	737	8,106	$512,426

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	382	3,228	$498,948
2016	463	3,742	$807,955
2017	448	3,666	$890,749
2018	468	3,379	$1,094,403
2019	529	3,711	$1,328,785
2020	521	4,184	$1,453,318
2021	609	4,478	$2,162,006
2022	655	4,756	$2,742,026
2023	716	5,075	$2,957,494
2024	767	5,681	$2,986,128

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	176	1,475	$337,744
2016	149	1,611	$522,500
2017	186	1,570	$446,180
2018	203	1,698	$812,267
2019	301	2,034	$1,101,521
2020	450	2,881	$1,941,767
2021	539	2,965	$1,949,275
2022	468	2,925	$2,126,851
2023	565	3,355	$2,176,176
2024	624	3,953	$2,862,216

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	581	1,337	$134
94726	Test to determine lung volumes using sensors	386	521	$44
94010	Test to measure expiratory airflow and volume	378	623	$21
95012	Test to measure the level of nitric oxide gas	268	400	$14
71046	X-ray of chest, 2 views	273	804	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	1,018	39,192	$805,812
Ofev	Nintedanib Esylate	49	1,470	$635,716
Dupixent Pen	Dupilumab	93	2,562	$345,126
Fasenra Pen	Benralizumab	34	1,848	$185,789
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	225	10,320	$159,876

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1558	Injection, immune globulin (xembify), 100 mg	N	22	231	$1,038,742
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	112	$520,672
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	62	$296,696
J1551	Injection, immune globulin (cutaquig), 100 mg	N	N/R	51	$207,322
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	56	$192,348

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	114	$9,307	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brion J. Lock, M.D.?

Tedicare shows public-source Medicare data for Brion J. Lock, M.D. (NPI 1295785731), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brion J. Lock, M.D. have ACO affiliation data?

Brion J. Lock, M.D. is shown with ACO affiliation data for Piedmont Clinic ACO LLC (MSSP, ACO ID A3250).

What billing organization is linked to Brion J. Lock, M.D.?

Brion J. Lock, M.D. is linked to PIEDMONT PROVIDERS LLC (billing NPI 1548273592) in the available physician profile data.

Does Brion J. Lock, M.D. have Open Payments data?

Brion J. Lock, M.D. has 114 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.